NasdaqCM - Delayed Quote • USD
Regencell Bioscience Holdings Limited (RGC)
At close: April 18 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | ||||
---|---|---|---|---|
EPS Est. | -- | -- | -- | -- |
EPS Actual | -- | -- | -- | -- |
Difference | -- | -- | -- | -- |
Surprise % | -- | -- | -- | -- |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | RGC | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 0.80% |
Next Qtr. | -- | -- | -- | 9.60% |
Current Year | -- | -- | -- | 4.50% |
Next Year | -- | -- | -- | 13.30% |
Next 5 Years (per annum) | -- | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Related Tickers
UPC Universe Pharmaceuticals INC
2.1900
+7.88%
RICH.BA Laboratorios Richmond S.A.C.I.F.
873.00
-3.00%
TKNO Alpha Teknova, Inc.
2.0100
-4.74%
QLI Qilian International Holding Group Limited
0.7701
-13.59%
HUGE FSD Pharma Inc.
0.4654
+0.19%
PROC Procaps Group S.A.
2.7000
-2.88%
PAHC Phibro Animal Health Corporation
13.04
+1.32%
CPIX Cumberland Pharmaceuticals Inc.
1.6500
+5.10%
PRFX PainReform Ltd.
0.8900
-0.22%
TAIPY Taisho Pharmaceutical Holdings Co., Ltd.
13.00
0.00%